Canadian Medical Discoveries Fund
20
15M
14
0.67
0.30
9
- Stages of investment
- Areas of investment
Summary
Canadian Medical Discoveries Fund is the famous VC, which was founded in 1994. The main department of described VC is located in the Halifax. The company was established in North America in Canada.
Comparing to the other companies, this Canadian Medical Discoveries Fund performs on 2 percentage points more the average number of lead investments. The top activity for fund was in 2008. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 14 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2013.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Canadian Medical Discoveries Fund, startups are often financed by GeneChem, BDC Venture Capital, Novo Holdings. The meaningful sponsors for the fund in investment in the same round are GrowthWorks Capital, BDC Venture Capital, GeneChem. In the next rounds fund is usually obtained by BDC Venture Capital, GrowthWorks Capital, VenGrowth Asset Management.
The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Cytochroma, Viron Therapeutics, Agrisoma Biosciences. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular fund investment industries, there are Health Care, Pharmaceutical.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 0
- Exits
- 9
- Rounds per year
- 0.67
- Follow on index
- 0.30
- Investments by industry
- Biotechnology (18)
- Pharmaceutical (10)
- Health Care (7)
- Clinical Trials (6)
- Medical (5) Show 8 more
- Investments by region
-
- Canada (12)
- United States (7)
- United Kingdom (1)
- Peak activity year
- 2008
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 71M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 1.76
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Gemin X Pharmaceuticals | 03 Jul 2008 | Biotechnology, Pharmaceutical, Therapeutics | Late Stage Venture | 38M | Quebec, Montreal, Canada |
| Protiva Biotherapeutics | 13 Jul 2006 | Biotechnology | Late Stage Venture | 5M | United States, Washington, Seattle |
| Shanghai LinkedCare Information Technology | 08 Dec 2017 | Health Care | Early Stage Venture | 15M | China, Shanghai |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.